GT-1036

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameGT-1036
Drug Alias Nameretinoid X receptor agonists (MaxoCore)retinoid X receptor agonists (Gerinda)RXR agonists (MaxoCore)MC-1011MC-1035 +[9] 
ClassificationSmall molecules
Mechanisms of ActionRetinoid X receptor agonistsApolipoprotein E agonists
TargetsRetinoid X receptorApolipoprotein E
Therapy Area/IndicationsHypercholesterolemiaDiabetes MellitusAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMaxoCore Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGerinda Therapeutics IncMaxoCore Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaDiabetes MellitusAlzheimer Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A